Understanding how epigenetic changes affect cancer development and treatment
Cancer Epigenetics Research Program
This study is looking at how changes in our genes can affect cancer and how we can use this information to create better treatments, so if you're dealing with cancer, this research might lead to new ways to help you.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-10933317 on NIH RePORTER |
What this research studies
The Cancer Epigenetics Research Program at the Sylvester Comprehensive Cancer Center investigates the role of epigenetic factors in cancer, particularly focusing on how these changes can influence cancer risk, progression, and resistance to treatment. The program employs a multidisciplinary approach, involving experts from various fields to explore molecular mechanisms and identify potential biomarkers for cancer. Patients may benefit from innovative therapeutic strategies developed through this research, which aims to improve cancer treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals diagnosed with acute myeloid leukemia or other cancers influenced by epigenetic changes.
Not a fit: Patients with cancers unrelated to epigenetic factors or those not diagnosed with acute myeloid leukemia may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies and biomarkers that enhance cancer treatment and patient outcomes.
How similar studies have performed: Previous research in cancer epigenetics has shown promising results, indicating that this approach has the potential for significant breakthroughs in cancer treatment.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Lombard, David Benner — University of Miami School of Medicine
- Study coordinator: Lombard, David Benner
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.